PRME Stock Analysis: Buy, Sell, or Hold?
PRME - Prime Medicine, Inc. Common Stock
$3.39
-0.09 (-2.59%)
▼
5d:
-6.61%
30d:
-19.86%
90d:
-1.45%
HOLD
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
PRME is down 12.0% this week, but smart money is accumulating calls. Top strike: $4 2026-05-15 with 7 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When PRME Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PRME shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PRME shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PRME is currently trading at $3.39, which is considered oversold relative to its 30-day fair value range of $3.43 to $4.17.
Technical Outlook: Technically, PRME is in a strong uptrend. Immediate support is located at $3.04, while resistance sits at $3.83.
Market Sentiment: PRME has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.92 (+104.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PRME is in a strong uptrend. Immediate support is located at $3.04, while resistance sits at $3.83.
Market Sentiment: PRME has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.92 (+104.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$3.43 -
$4.17
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding PRME? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 104.0% below Wall St target ($6.92)
- CAUTION: 5-day price weakness (-6.6%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$3.43 -
$4.17
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$3.04
Resistance Level
$3.84
Current Trend
Strong Uptrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.17
Wall Street Target
$6.92
(+104.0%)
Revenue Growth (YoY)
-61.6%
Share & Embed Analysis
Last updated: April 02, 2026 5:30 AM ET
Data refreshes hourly during market hours. Next update: 6:30 AM
Data refreshes hourly during market hours. Next update: 6:30 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRME showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 55 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$132 | 56 HOLD |
Advanced PRME Option Strategies
Professional options setups generated by AI based on today's PRME price and gamma walls.
